ICD-10 Coding for Metastatic Breast Cancer(C22.0P, C50.0, C50.911)
Explore comprehensive ICD-10 coding guidelines for metastatic breast cancer, including primary and secondary site codes, documentation requirements, and common pitfalls.
Complete code families applicable to Metastatic Breast Cancer
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C50.911 | Malignant neoplasm of unspecified site of right female breast | When breast cancer is confirmed but specific site is not documented. |
|
| C78.7 | Secondary malignant neoplasm of liver | When breast cancer has metastasized to the liver. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMetastatic Breast Cancer
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Metastatic Breast Cancer.
Failing to document hormone receptor status.
Impact
Clinical: May affect treatment decisions., Regulatory: Non-compliance with coding guidelines., Financial: Potential for reduced reimbursement.
Mitigation
Always include lab results for ER/PR status., Use templates to ensure completeness.
Using unspecified codes when specific site is documented.
Impact
Reimbursement: May lead to reduced reimbursement., Compliance: Increases risk of audits., Data Quality: Decreases accuracy of clinical data.
Mitigation
Always document and code specific site and laterality.
Unspecified codes
Impact
Use of unspecified codes can trigger audits.
Mitigation
Ensure documentation supports specific coding.